Clinical Trial: Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19
Study Status: Completed
Recruit Status: Completed
Condition: COVID-19
Study Type: Interventional
Official Title: An Open Randomized Multicenter Comparative Study to Evaluate the Efficacy, Safety and Tolerability of the Use of Ambervin® for Intramuscular Administration and for Inhalation in Patients Hospitalized
Brief Summary:
This is open-labe randomized multicenter comparative Phase III study conducted in 8 medical facilities. The objective of the study is to assess the efficacy, safety and tolerability of Ambervin for intramuscular and inhaled administration in complex therapy COVID-19 compared with the Standard of care (SOC) in hospitalized patients with moderate COVID-19.
Read more